$1.22
0.021.67%
At close: -
$1.20
-0.02-1.59%
After Hours: 8:26 AM EDT
RAPT Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of RAPT Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-0.47 | $-0.54 | 13.0 % |
Q2 | 2024-08-08 | $-0.71 | $-0.72 | 1.39 % |
Q1 | 2024-05-09 | $-0.79 | $-0.81 | 2.47 % |
Q4 | 2024-03-07 | $-0.80 | $-0.86 | 6.98 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2023-03-14 | $0 | $220.00K | -100.0 % |
Q3 | 2022-11-10 | $0 | $340.00K | -100.0 % |
Q2 | 2022-08-11 | $886.00K | $280.00K | 216.4 % |
Q1 | 2022-05-11 | $641.00K | $220.00K | 191.4 % |
RAPT Therapeutics (RAPT) is scheduled to report earnings on March 6, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.47, which beat the estimate of $-0.54.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.